David J. Brailer
Known title: EVP & Chief Health OfficerCIK: 0001222879
Associated companies
Transaction History
| CI | ▼ Sell | Tax Withholding | 290 | $87K | 8/29/2025 | View on chart |
| CI | ▲ Buy | Grant | 6,540 | $0 | 2/28/2025 | View on chart |
| CI | ▲ Buy | Grant | 5,640 | $0 | 2/28/2025 | View on chart |
| CI | ▼ Sell | Tax Withholding | 775 | $237K | 2/28/2025 | View on chart |
| CI | ▼ Sell | Tax Withholding | 2,632 | $805K | 2/28/2025 | View on chart |
| CI | ▼ Sell | Tax Withholding | 290 | $105K | 8/30/2024 | View on chart |
| CI | ▲ Buy | Grant | 2,780 | $0 | 3/1/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 412 | $137K | 3/1/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 1,099 | $366K | 3/1/2024 | View on chart |
| CI | ▲ Buy | Grant | 3,121 | $0 | 2/28/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 202 | $56K | 9/1/2023 | View on chart |
| CI | ▲ Buy | Grant | 3,395 | $0 | 2/22/2023 | View on chart |
| CI | ▲ Buy | Grant | 1,749 | $0 | 9/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.